We can’t show the full text here under this license. Use the link below to read it at the source.
Loss of SMN Impairs Osteoblast–Osteoclast Coupling via IGF1 –Akt– OPG Axis in Spinal Muscular Atrophy
Loss of SMN May Disrupt Bone-Building and Bone-Breaking Cell Interaction Through IGF1-Akt-OPG Pathway in Spinal Muscular Atrophy
AI simplified
Abstract
SMA mice exhibited significant bone mass reduction characterized by impaired bone formation and increased bone resorption.
- Osteogenesis was impaired, while osteoclastogenesis was increased in SMA mice.
- In vitro findings showed suppressed osteoclast differentiation from bone marrow-derived macrophages in SMA mice, contrasting with in vivo results.
- Osteoclast hyperactivity was linked to decreased osteoblast-derived (OPG), driven by local (IGF1) deficiency.
- SMN protein loss led to IGF1 downregulation, which inhibited the PI3K-Akt signaling pathway and reduced OPG expression.
- Exogenous OPG administration mitigated osteoclast differentiation and promoted osteoblast function, partially restoring bone formation.
AI simplified
Key numbers
60%
Decrease in
Measured in 3-month-old mice vs. control mice.
Not specified
Increase in RANKL/ Ratio
Observed in mice compared to controls.